Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's request for sensitive data.
This rejection was revealed after a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".
A government spokesman later explained that the United States was seeking health data for scientific study and profit but refused to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Implications
This development comes after a similar case in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.
As per reports, Sixteen nations in Africa have so far signed these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the final treatments would be available to our citizens should a future disease outbreak emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining structures already established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.
"This framework is designed to ensure that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to further discussions with our US partners on how future co-operation might be structured in a way that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that talks need to persist given that much of the country's HIV programmes were funded by international support.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal emphasises the complex debate between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.